Lyme disease research studies often require generation of ticks infected with the pathogen Borrelia burgdorferi, a process that typically takes several weeks. Here we demonstrate a microinjection-based tick infection procedure that can be accomplished within hours. We also demonstrate an immunofluorescence method for in situ localization of B. burgdorferi within ticks.
Lyme disease is caused by infection with the spirochete pathogen Borrelia burgdorferi, which is maintained in nature by a tick-rodent infection cycle 1. A tick-borne murine model 2 has been developed to study Lyme disease in the laboratory. While naíve ticks can be infected with B. burgdorferi by feeding them on infected mice, the molting process takes several weeks to months to complete. Therefore, development of more rapid and efficient tick infection techniques, such as a microinjection-based procedure, is an important tool for the study of Lyme disease 3,4. The procedure requires only hours to generate infected ticks and allows control over the delivery of equal quantities of spirochetes in a cohort of ticks. This is particularly important as the generation of B. burgdorferi infected ticks by the natural feeding process using mice fails to ensure 100% infection rate and potentially results in variation of pathogen burden amongst fed ticks. Furthermore, microinjection can be used to infect ticks with B. burgdorferi isolates in cases where an attenuated strain is unable to establish infection in mice and thus can not be naturally acquired by ticks 5. This technique can also be used to deliver a variety of other biological materials into ticks, for example, specific antibodies or double stranded RNA 6. In this article, we will demonstrate the microinjection of nymphal ticks with in vitro-grown B. burgdorferi. We will also describe a method for localization of Lyme disease pathogens in the tick gut using confocal immunofluorescence microscopy.
1. Microinjection of Nymphal Ixodes scapularis Ticks
1. Preparing needles
2. Preparing B. burgdorferi
3. Preparing ticks
4. Injecting ticks
2. B. burgdorferi Localization by Confocal Immunofluorescence Microscopy
1. Dissecting ticks
2. Staining
3. Representative Results
Position of a nymphal tick for microinjection and an image representing B. burgdorferi localization in the tick gut is presented in Figure 1.
Figure 1. Microinjection and localization of B. burgdorferi into the tick gut.
(A) Ventral view of a nymphal I. scapularis tick positioned for microinjection. Anal aperture (arrowhead) with inserted microinjection needle (arrow) is shown under magnification in the inset. A fine forcep is used to apply gentle pressure to the body, which allowed separation of the anal plates and opening of the anal pore for microinjection. The needle is filled with a solution of Coomassie brilliant blue to enhance visibility. (B) Representative results of confocal immunofluorescence imaging of B. burgdorferi within tick gut. Anterior region of a gut diverticulum is shown. Gut nuclei and spirochetes (arrow) are labeled with propidium iodide (red color) or FITC-conjugated anti-B. burgdorferi (green color), respectively. Bar = 20 μm.
Here we demonstrate a microinjection-based procedure for rapid and efficient infection of nymphal Ixodes ticks with the bacterial pathogen B. burgdorferi. We also describe a confocal immunofluorescence procedure for the detection of B. burgdorferi in the tick gut in situ. Although our demonstration involves nymphal gut, similar procedures are also applicable for other developmental stages of ticks, such as larva or adults 8,9. However, due to their smaller size, the technique may be relatively challenging for use in larvae, but should be well applicable for use in adult ticks. Other methods of artificial infection of ticks with B. burgdorferi have been developed, such as feeding through glass capillary tubes 10 or by immersion in the culture medium 11. These methods are efficient, simpler and relatively inexpensive. However, these procedures rely on relatively uncontrolled transfer of B. burgdorferi into individual ticks and thus potentially are limited in generating cohorts of infested ticks with equal pathogen burdens. The latter shortcoming could be substantially overcome by more controlled delivery procedures, such as microinjection. In our laboratory, we routinely employ this procedure to transfer B. burgdorferi into ticks with infection rates of nearly 100%, and most ticks survive the procedure. Injected ticks can be kept in the laboratory for several weeks to months, or immediately allowed to engorge on mice and transmit B. burgdorferi infection. The efficiency and kinetics of B. burgdorferi transmission from microinjected ticks are similar to that of naturally-infected ticks, and therefore, artificial tick infection procedures are likely to assist in our efforts to study tick-borne Lyme borreliosis. Additionally, similar microinjection techniques have also been applied for related experimental purposes, for example, RNA interference-mediated genetic manipulation of ticks 6,9,12.
Microinjection of immature stages of ticks is a relatively delicate procedure. It is thus important to verify that the ticks injected with B. burgdorferi are healthy before proceeding to the next set of experiments. Post-injected ticks that have retracted legs and are unresponsive to stimuli, such as exhaled breath or touching with a brush, should not be used for further experiments. These are most likely dead or on the verge of dying from the injection trauma. We have found that the size of the needle tip and injection parameters are the two critical factors in the procedure, as larger needle tips and injection volumes could potentially rupture the gut wall resulting in high tick mortality. It is also important to note that the microinjection settings described here are primarily optimized for injecting B. burgdorferi suspended in BSK media. Other biological materials, such as antibodies or concentrated RNA solutions, could differ in fluid viscosity. For other materials, the optimal microinjection settings, primarily the injection pressure and injection time, need to be determined empirically.
The authors have nothing to disclose.
We sincerely thank members of the Pal laboratory for assistance with the preparation of this demonstration. This study was supported by PHS grants AI076684 and AI080615 from NIH/NIAID.
Material Name | Type | Company | Catalogue Number | Comment |
---|---|---|---|---|
Glass capillary tubes | World Precision Instruments | TW100F-4 | ||
Vertical glass puller | Narishige | PC-10 | ||
Petroff-Hausser counting chamber | Hausser scientific | 3900 | ||
Microloader pipette tips | Eppendorf | 930001007 | ||
Femtojet microinjector | Eppendorf | 920010504 | ||
Foot control FemtJet | Eppendorf | 920005098 | ||
Phosphate buffered saline | Fisher Scientific | BP665-1 | Filter-sterilized |